Genelux Insider Trades

GNLX

Track insider trading activity from Genelux executives and directors. See which insiders are buying and selling GNLX stock.

Trades Last 12 Months

GNLX Price

All Insider Trades for Genelux

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Thomas John Director
Holding Value $1.42M 472,784 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.8k 10,000 shares
$2.98
$3.00
Cappello Joseph Chief Technical Officer
Holding Value $464k 154,549 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.8k 605 shares
$2.97
$3.00
Smalling Ralph Head Of Regulatory
Holding Value $203k 67,803 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$805 270 shares
$2.98
$3.00
Yu Yong Chief Scientific Officer
Holding Value $449k 149,706 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.8k 605 shares
$2.97
$3.00
Zindrick Thomas President And CEO
Holding Value $1.6M 532,051 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.23k 2,798 shares
$2.94
$3.00
Litten Jason Chief Medical Officer
Holding Value $825k 275,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.25M 275,000 shares
$4.55
$3.00
Smither John W Director
Holding Value $225k 74,994 shares
Last Trade
Aug 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 28,576 shares
$3.64
$3.00
Mirabelli Mary Director
Holding Value $220k 73,284 shares
Last Trade
Aug 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 28,576 shares
$3.64
$3.00
Tyree James L Director
Holding Value $204k 68,074 shares
Last Trade
Aug 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 28,576 shares
$3.64
$3.00
Groen Eric General Counsel & Secretary
Holding Value $810k 270,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$764k 270,000 shares
$2.83
$3.00
Ryder Sean General Counsel
Holding Value $143k 47,621 shares
Last Trade
May 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.1k 4,475 shares
$2.92
$3.00
Pulisic Matthew Chief Financial Officer
Holding Value $825k 275,000 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09M 275,000 shares
$3.95
$3.00
Zak Lourie S. Chief Financial Officer
Holding Value $247k 82,452 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 56,525 shares
$2.29
$3.00
Scigalla Paul Chief Medical Officer
Holding Value $50k 16,666 shares
Last Trade
Oct 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.8k 16,666 shares
$2.75
$3.00
Szalay Aladar 10% owner
Holding Value $1.8M 599,821 shares
Last Trade
Sep 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$85k 33,080 shares
$2.57
$3.00
Jewett Caroline Head Of Quality
Holding Value $48.5k 16,174 shares
Last Trade
Jun 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.5k 4,961 shares
$2.12
$3.00
Samuelson Doug Vice President, Finance
Holding Value $120k 40,000 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$896k 40,000 shares
$22.40
$3.00
Zhang Qian Associate Vp, Research
Holding Value $418k 139,333 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.4k 6,000 shares
$6.57
$3.00
Woodward Gabe Director
Holding Value $12.6k 4,186 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.57k 1,000 shares
$6.57
$3.00
Yu Tony Vp, Clinical Trial Operations
Holding Value $477k 159,000 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 9,000 shares
$6.57
$3.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up